CORRECTION
Friday, 10 September, 2004
An article published on September 8, headlined 'Nucleonics challenges Benitec-CSIRO RNAI patent' contained errors relating to the timing of the filing of key patents.
It should have stated that a patent application by The Carnegie Institution of Washington and The University of Massachusetts (the Fire-Mello invention) was first filed in the US in December 1997. The Fire-Mello invention has an earlier priority date than the Benitec and CSIRO applications, which were first filed in Australia.
A patent application by Syngenta, directed to a vector for enhancing the inhibition of a selected target gene, was also filed before the Benitec and CSIRO applications.
Inhaled form of blood thinner treats serious COVID infections
Heparin has traditionally been injected and used to treat blood clots, but the new study tested...
Next-gen therapies could treat high-grade gliomas
Government funding will enable researchers to test a suite of next-generation therapies they have...
Bacteriophage cocktail to combat superbugs
Entelli-02 is a five-phage cocktail designed specifically to target Enterobacter cloacae...
